As part of its regulatory review of software and AI-based medical devices, the administration wants to hear from developers and users.
As part of its regulatory review of software and AI-based medical devices, the administration wants to hear from developers and users.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.